These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11855679)

  • 101. A Novel Drug-Drug Cocrystal of Levofloxacin and Metacetamol: Reduced Hygroscopicity and Improved Photostability of Levofloxacin.
    Shinozaki T; Ono M; Higashi K; Moribe K
    J Pharm Sci; 2019 Jul; 108(7):2383-2390. PubMed ID: 30807761
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Intravenous colistimethate administration and colistin lung tissue concentrations.
    Imberti R
    Intensive Care Med; 2010 Oct; 36(10):1795. PubMed ID: 20652684
    [No Abstract]   [Full Text] [Related]  

  • 103. [Experimental comparative pharmacokinetics of levofloxacin, triazavirin, and related conjugate].
    Blazhennikova IV; Kurliakova AF; Bykov VN; Geĭbo DS; Nikiforov AS; Stepanov AV; Charushin VN; Chupakhin ON; Kotovskaia SK; Rusinov VL
    Eksp Klin Farmakol; 2015; 78(2):34-8. PubMed ID: 25898546
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Vancomycin entry into lung lymph in sheep.
    May DG; Stratton CW; Denney WD; Watts FL; Bernard GR; Branch RA
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1689-91. PubMed ID: 3435116
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Entry of five antifungal agents into the ovine lung.
    Hoeprich PD; Merry JM; Gunther R; Franti CE
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1234-7. PubMed ID: 3631944
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The pulmonary biopharmaceutics and anti-inflammatory effects after intratracheal and intravenous administration of Re-Du-Ning injection.
    Jia-Xing W; Chao-Yi L; Wei-Ya C; Yi-Jun C; Chun-Yu L; Fei-Fei Y; Yong-Hong L
    Biomed Pharmacother; 2023 Apr; 160():114335. PubMed ID: 36724641
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Physiologically-based pharmacokinetic analysis of grepafloxacin.
    Nakajima Y; Hattori K; Shinsei M; Matsunaga N; Iizasa H; Sasabe H; Akiyama H; Miyanmoto G; Nakashima E
    Biol Pharm Bull; 2000 Sep; 23(9):1077-83. PubMed ID: 10993208
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Fluoroquinolone concentrations in plasma, urine, and bile after oral administration in rats with renal failure: useful technique for long-term bile collection.
    Mizuta K; Hishikawa S; Hirota M; Miyamoto G; Fujimura A; Hakamata Y; Kobayashi E
    J Med; 2001; 32(5-6):311-20. PubMed ID: 11958277
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Distribution characteristics of grepafloxacin, a fluoroquinolone antibiotic, in lung epithelial lining fluid and alveolar macrophage.
    Deguchi Y; Sun J; Tauchi Y; Sakai S; Morimoto K
    Drug Metab Pharmacokinet; 2003; 18(5):319-26. PubMed ID: 15618751
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.
    Rodvold KA; Danziger LH; Gotfried MH
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2450-7. PubMed ID: 12878504
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Lung tissue distribution after intravenous administration of grepafloxacin: comparative study with levofloxacin.
    Yamamoto H; Koizumi T; Hirota M; Kaneki T; Ogasawara H; Yamazaki Y; Fujimoto K; Kubo K
    Jpn J Pharmacol; 2002 Jan; 88(1):63-8. PubMed ID: 11855679
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Pharmacokinetics of grepafloxacin.
    Efthymiopoulos C
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():35-43. PubMed ID: 9484872
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients.
    Pea F; Furlanut M
    J Chemother; 2004 Apr; 16 Suppl 2():8-10. PubMed ID: 15255555
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.